26 February 2020

Arnt Schellekens has been appointed professor of Addiction and Psychiatry at Radboud University / Radboud university medical center with effect from 1 January 2020.

Arnt Schellekens (Loon op Zand, 1977) studied medicine at Radboud University and graduated cum laude in 2003 with a Master's degree in medicine. He specialised in psychiatry and in 2011 he obtained his PhD on research into alcohol addiction, in particular the relationship between genetic and environmental factors.
Arnt Schellekens has been working as a psychiatrist at Radboud university medical center since 2012, where he further specialised in addiction, and was appointed as head of the medical-psychiatric unit in 2017. His research focuses on neurobiological and psychological mechanisms that contribute to addiction. He aims to better understand why patients with addictive behaviour often also suffer from other psychiatric disorders (for example ADHD and depression) or vice versa. His ultimate goal is to develop more effective treatment strategies based on these insights.

Key role in addiction research

During his training as a psychiatrist, Schellekens also worked on HIV/AIDS research in Bandung, Indonesia. Besides his clinical work as a psychiatrist, he is a researcher at the Donders Institute for Brain, Cognition and Behaviour, and coordinator of a large number of research projects. He is also a postdoctoral researcher at the Nijmegen Institute for Scientist Practitioners in Addiction (NISPA), where he has been scientific director since 2015.
By the combination of clinical work, scientific research and his position as scientific director of NISPA, Schellekens plays a key role in the collaboration between addiction care facilities, neuroscientific colleagues from the Donders Institute and behavioural scientists from the Behavioural Science Institute (BSI).

Addiction Medicine training

Arnt Schellekens has given addiction medicine training an important place in the medical curriculum, is principal lecturer in the national masters program on addiction medicine, and coordinator of the national addiction psychiatry curriculum.
 
 

Related news items


Dutch Cancer Society Grant received by Annemiek van Spriel and Laia Querol-Cano

23 September 2020

Annemiek van Spriel and Laia Querol-Cano received a Dutch Cancer Society Grant of 700K euros to study the cancer cell surface in immunotherapy.

read more

Tumor cells stimulate lipid biosynthesis in macrophages

23 September 2020

RIMLS researchers wrote in the Journal for ImmunoTherapy of Cancer that improved lipid biosynthesis in human tumor-induced macrophages contributes to their protumoral characteristics.

read more

Frank Walboomers 25-years work anniversary at Radboudumc

17 September 2020

Frank Walboomers, associate professor at the research group Regenerative Biomaterials at the Dept. of Dentistry (theme Reconstructive & Regenerative Medicine), celebrated his 25th work anniversary at Radboudumc.

read more

Tjitske Kleefstra appointed endowed professor of Clinical genetics and psychopathology of rare syndromes

17 September 2020

Tjitske Kleefstra has been appointed endowed professor of Clinical genetics and psychopathology of rare syndromes at the department of Neurodevelopmental disorders, with effect from 1 September.

read more

Annette Schenck appointed professor of Translational Genomics of Neurodevelopmental Disorders

17 September 2020

Annette Schenck has been appointed professor of Translational Genomics of Neurodevelopmental Disorders. with effect from 1 August. The chair will bring together fundamental and translational research in the field of brain developmental disorders.

read more

Transfer of new anti-hepatitis C drugs across the human placenta

9 September 2020

In a recent publication in American Journal of Obstetrics and Gynecology, researchers from the Departments of Pharmacology and Toxicology, Pharmacy, Obstetrics and Gynecology, Gastroenterology and Hepatology, investigated the placental passage of two such drugs for the first time.

read more